Incubation with extracellular vesicles boosts cells’ grafting ability
The research could potentially overcome serious complications due to graft failure or poor engraftment from allogeneic stem cell…
Author
India’s childhood leukaemia survival rate leaps to 80 per cent
Professor Saha, has helped cure children diagnosed with acute lymphoblastic leukaemia by 15 per cent during five years he has led…
DuPont, BioMe Oxford to co-develop and bring to market smart capsule to sample gut microbiota
The DuPont Microbiome Venture has announced a strategic investment and partnership with BioMe Oxford. BioMe Oxford is an early…
How Jan Aushadhi will change the game for pharma
Dr Vikram Munshi, Founder and Principal Consultant, Whitespace Consulting and Capability Building, evaluates the state of Jan…
Opportunity for Indian pharma industry to capitalise on escalating US-China trade war: GlobalData
Both China and the US are key markets for India from the pharma industry perspective
It’s been more than a year since China and…
The government should consider it as national emergency-Dr B Krishna Murthy
Self-sufficiency in bulk drugs remains a distant dream as India remains import dependent with over dependence on China, even for…
There is a need to focus on skill development-Dr Sanjit Singh Lamba
Emerging economies have been struggling with the absence of quality healthcare, and the biggest challenge in healthcare today…
Changing the mindset for education can definitely be a game changer-KV V Raju
First, it is important to understand the comparison between India and China's economy from a business
perspective. China is now…
How pharma companies can minimise API dependency from China?-Anant Barbadikar
Pharma Companies, over a period of last 25 years, have gradually started depending on China. Many companies started buying APIs.…
Indian cos need to explore on putting up facilities in dedicated pockets-Suresh Kamath
Indian pharma companies have a lot of manufacturing sites across the country. However, the economics of scale of units here is…
